Pharming
Manufacturing · Netherlands · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Vondellaan 47, Leiden, South Holland, 23...Phone Number
+31 715247400Website
www.pharming.comRevenue
$362.3 MillionStock Symbol
PHARMIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
3
1
1
1
1
About Pharming
Pharming Group N.V. is a global biopharmaceutical company focused on developing and commercializing innovative protein replacement therapies and precision medicines. Their mission is to serve the unserved rare disease patient community by addressing unmet medical needs. The company engages with various stakeholders including investors and partners to drive growth and innovation. They are committed to attracting talented individuals dedicated to improving the lives of patients.Explore more
Pharming Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pharming your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Pharming is spiking on competitors!
Pharming, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Pharming recently announced quarterly report
Check if Pharming has recently received funding, and reach out quickly before it becomes old news!
Click to see if Pharming had a recent Job posting/layoffs
Product Launch: Get notified when Pharming launches new products
Funding: Get notified immidiatlly once Pharming has new funding data
Congratulate Masked Content for being promoted to Masked Content at Pharming
Recommended Actions
Find VP level buyers at Pharming
Find 3 more new buyers
Company Profile Activity
Activity Insights
Pharming is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pharming is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pharming.
Pharming financials insights
Gather financial insights about Pharming, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Debt
$17M
2017
Debt
$100M
Pharming Tech Stack
A closer look at the technologies used by Pharming
See more technologies
Most Recent Scoops
Open Position
Person-Based
Events
Person-Based
Events
Open Position
Hiring Plans
Hiring Plans
Pharming News & Media
Pharming Group to participate in Fireside Chat at 2026 Jefferies Global Healthcare Conference in New York
Pharming Group to participate in Fireside Chat at 2026 Jefferies Global Healthcare Conference in New York. Thursday June 4, 2026 at 11:05 EDT/17:05 CEST.Pharming Group announces results of 2026 Annual General Meeting of Shareholders
Pharming Group announced that shareholders approved all proposals presented at its Annual General Meeting of Shareholders (AGM), held on May 28, 2026.European Commission grants marketing authorization to Pharming’s Joenja® (leniolisib) – the first approved treatment for APDS in the European Union
Pharming announces the European Commission (EC) has granted Marketing Authorization for Joenja (leniolisib)Pharming Group N.V. (PHAR) Q1 2026 Earnings Call Transcript
Pharming Group N.V. (PHAR) Q1 2026 Earnings Call May 7, 2026 7:30 AM EDTCompany ParticipantsFabrice Chouraqui - CEO & Executive DirectorLeverne Marsh -...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pharming
Sign Up For FreeTo access detailed company insights
Pharming Group N.V. is a global biopharmaceutical company focused on developing and commercializing innovative protein replacement therapies and precision medicines. Their mission is to serve the unserved rare disease patient community by addressing unmet medical needs. The company engages with various stakeholders including investors and partners... Read More
